Behavioral Sciences (Jun 2019)

Speech-Stimulating Substances in Autism Spectrum Disorders

  • María Andrea Castillo,
  • Kendy Eduardo Urdaneta,
  • Neomar Semprún-Hernández,
  • Anna Lisa Brigida,
  • Nicola Antonucci,
  • Stephen Schultz,
  • Dario Siniscalco

DOI
https://doi.org/10.3390/bs9060060
Journal volume & issue
Vol. 9, no. 6
p. 60

Abstract

Read online

Autism spectrum disorder (ASD) is characterized by the core domains of persistent deficits in social communication and restricted-repetitive patterns of behaviors, interests, or activities. A heterogeneous and complex set of neurodevelopmental conditions are grouped in the spectrum. Pro-inflammatory events and immune system dysfunctions are cellular and molecular events associated with ASD. Several conditions co-occur with ASD: seizures, gastro-intestinal problems, attention deficit, anxiety and depression, and sleep problems. However, language and speech issues are key components of ASD symptoms current therapies find difficult to face. Several speech-stimulating substances have been shown to be effective in increasing speech ability in ASD subjects. The need for large clinical trials to determine safety and efficacy is recommended.

Keywords